CIT and cancer: Importantly, these results, along with the lack of correlation between the p53 status and susceptibility to CIT-K depletion (Figure 9A), indicate that cytokinesis failure could be an effective anti-proliferative approach for treating cancers carrying either wild type or mutated p53.